May 15, 2020 / 02:00PM GMT
Presentation at ASGCT Annual Meeting
May 15, 2020 / 02:00PM GMT
=====================
Corporate Participants
=====================
* Charles E. Triano
Pfizer Inc. - SVP of IR
* Michael Binks
Pfizer Inc. - Vice President, Rare Disease Clinical Research
* Mikael Dolsten
Pfizer Inc. - Chief Scientific Officer and President of Worldwide Research, Development & Medical
* Seng Cheng
Pfizer Inc. - Chief Scientific Officer and Senior Vice President, Rare Disease
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc, Research Division - Global Head of Healthcare Research and MD
* Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
* David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
* Terence C. Flynn
Goldman Sachs Group Inc., Research Division - MD
* Umer Raffat
Evercore ISI Institutional
Pfizer Inc
(MIL:1PFE)
€
21.45
+0.23 (+1.08%)
Market Cap: 122.52 Bil
Enterprise Value: 167.26 Bil
PE Ratio: 18.45
PB Ratio: 1.53
GF Score: 47/100 Pfizer Inc Conference Call to Review DMD Data Presentation at ASGCT Annual Meeting Transcript
May 15, 2020 / 02:00PM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot